Université Côte d'Azur, INSERM, U1065, C3M, 06200 Nice, France.
Biomedical Neuroscience Institute (BNI), Faculty of Medicine, University of Chile, Santiago, Chile; Center for Geroscience, Brain Health and Metabolism (GERO), Santiago, Chile; Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile.
J Hepatol. 2018 Oct;69(4):927-947. doi: 10.1016/j.jhep.2018.06.008. Epub 2018 Jun 27.
The global epidemic of obesity has been accompanied by a rising burden of non-alcoholic fatty liver disease (NAFLD), with manifestations ranging from simple steatosis to non-alcoholic steatohepatitis, potentially developing into hepatocellular carcinoma. Although much attention has focused on NAFLD, its pathogenesis remains largely obscure. The hallmark of NAFLD is the hepatic accumulation of lipids, which subsequently leads to cellular stress and hepatic injury, eventually resulting in chronic liver disease. Abnormal lipid accumulation often coincides with insulin resistance in steatotic livers and is associated with perturbed endoplasmic reticulum (ER) proteostasis in hepatocytes. In response to chronic ER stress, an adaptive signalling pathway known as the unfolded protein response is triggered to restore ER proteostasis. However, the unfolded protein response can cause inflammation, inflammasome activation and, in the case of non-resolvable ER stress, the death of hepatocytes. Experimental data suggest that the unfolded protein response influences hepatic tumour development, aggressiveness and response to treatment, offering novel therapeutic avenues. Herein, we provide an overview of the evidence linking ER stress to NAFLD and discuss possible points of intervention.
全球肥胖症的流行伴随着非酒精性脂肪性肝病 (NAFLD) 的负担不断增加,其表现从单纯性脂肪变性到非酒精性脂肪性肝炎不等,可能发展为肝细胞癌。尽管人们对 NAFLD 给予了高度关注,但它的发病机制在很大程度上仍不清楚。NAFLD 的标志是肝脏脂质的积累,这随后导致细胞应激和肝损伤,最终导致慢性肝病。在脂肪变性的肝脏中,异常脂质积累通常与胰岛素抵抗同时发生,并与肝细胞内质网 (ER) 蛋白质稳态紊乱有关。为了应对慢性 ER 应激,一种称为未折叠蛋白反应的适应性信号通路被触发,以恢复 ER 蛋白质稳态。然而,未折叠蛋白反应会引起炎症、炎症小体激活,并且在不可解决的 ER 应激情况下,导致肝细胞死亡。实验数据表明,未折叠蛋白反应会影响肝脏肿瘤的发展、侵袭性和对治疗的反应,为治疗提供了新的途径。在此,我们概述了将 ER 应激与 NAFLD 联系起来的证据,并讨论了可能的干预点。